Betta Pharmaceuticals Co., Ltd.

This study tests a combination of two drugs, MCLA-129 and ensartinib hydrochloride, in people with advanced solid tumors that cannot be removed by surgery or cured. The goal is to see if the combination is safe and can shrink or control the tumors. About 164 adults aged 18-75 wit…

This study is for people with a common type of advanced lung cancer (non-small cell) that has stopped responding to current targeted pills. The trial will test a two-step approach: first, standard chemotherapy, then a newer targeted drug called befotertinib. The goal is to see if…

This study tests a new drug called MCLA-129 in people with advanced solid tumors like lung, head and neck, or colorectal cancer that has not responded to standard treatments. The drug is a bispecific antibody designed to attach to two cancer-related proteins (EGFR and c-Met) to b…